(Reuters) – U.S. stocks climbed on Monday as gains in Amazon and Nike as well as a surprise rebound in U.S. factory activity helped markets attempt a recovery from steep weekly losses due to concerns about the coronavirus epidemic.
A trader works on the floor of the New York Stock Exchange shortly after the opening bell in New York, U.S., February 3, 2020. REUTERS/Lucas Jackson
ISM data showed the manufacturing sector expanded in January after five straight months of contraction, indicating that a prolonged slump in business investment has probably bottomed out.
“Sure we’ve been held back on worries about coronavirus, but this morning it’s been a story of data showing U.S. economy is really strong,” said John Brady, managing director at R.J. O’Brien & Associates in Chicago.
Google-parent Alphabet Inc (GOOGL.O) gained 2.7% ahead of its quarterly results, which will wrap up earnings for the so-called FAANG group of stocks.
Also helping the mood was an intervention by China’s central bank to improve liquidity and relieve pressure on its economy from the impact of the virus outbreak.
Concerns over the financial impact of the flu-like virus escalated last week after the World Health Organization declared it as a global emergency.
“It may have been overdone last week. It’s very hard to get a grasp of things like pandemics. We’re still in the spreading stage and it’s difficult to say whether it’s over or not,” Brady said.
At 11:31 a.m. ET, the Dow Jones Industrial Average .DJI was up 228.60 points, or 0.81%, at 28,484.63, the S&P 500 .SPX was up 27.65 points, or 0.86%, at 3,253.17. The Nasdaq Composite .IXIC was up 122.45 points, or 1.34%, at 9,273.39.
The consumer discretionary index .SPLRCD gained 1.1%, the most among the 11 major S&P indexes, while technology .SPLRCT stocks provided the biggest support to the benchmark index.
Gilead Sciences Inc (GILD.O) gained 4.3% after the drugmaker said it has provided its experimental Ebola therapy for use in a small number of patients affected by the coronavirus in China.
Exxon Mobil Corp (XOM.N) dropped 2.4% after Goldman Sachs downgraded the oil major’s shares to “sell”.
Advancing issues outnumbered decliners by a 2.31-to-1 ratio on the NYSE and by a 2.31-to-1 ratio on the Nasdaq.
The S&P index recorded 23 new 52-week highs and seven new lows, while the Nasdaq recorded 51 new highs and 54 new lows.
Reporting by Medha Singh and Sruthi Sankar in Bengaluru; Editing by Arun Koyyur